The primary aim was to investigate the relative importance of the adipocytes vs the nonfat cells present in human adipose tissue with respect to release of immunoreactive tumor necrosis factor-a (TNFa). The second aim was to examine the correlation between body mass index (BMI) and the subsequent release of adiponectin and TNFa by explants of human subcutaneous and visceral adipose tissue incubated in primary culture for 48 h. RESULTS: We found that the maximal release of TNFa was seen during the first 4 h of a 48-h incubation by explants of human adipose tissue in primary culture. Over 95% of the TNFa released to the medium by human adipose tissue explants over a 4-h incubation came from the nonfat cells present in the adipose tissue. The release of TNFa by the nonfat cells released during collagenase digestion was slightly higher than that by the cells present in the adipose tissue matrix after collagenase digestion. TNFa release by the combined matrix and isolated nonfat cells was greater than that by explants of tissue indicating some upregulation induced by collagenase digestion. Immunoreactive TNFa disappeared from the medium with a half-time of approximately 10 h. There was a positive correlation coefficient of 0.79 between TNFa release by tissue explants and the BMI of the fat donors as well as a correlation of 0.52 between BMI and release by adipocytes. TNFa release negatively correlated [À0.60] with adiponectin release by adipose tissue. The release of TNFa was far less than that of adiponectin or IL-6, and less than that of plasminogen activator inhibitor-1, hepatocyte growth factor, or leptin over a 4-h incubation of human adipose tissue explants. TNFa release over 4 h was enhanced by lipopolysaccharide and inhibited by a cyclooxygenase-2 inhibitor. CONCLUSION: The release of TNFa by adipose tissue of obese humans is primarily due to the nonfat cells present in adipose tissue. TNFa is a short-lived adipokine whose release by human adipose tissue in primary culture correlates with the BMI of the fat donors.
Introduction
Hotamisligil et al 1 first demonstrated that the mRNA for tumor necrosis factor-a (TNFa) is elevated in adipose tissue of obese humans and that over a 2-h incubation there was greater release of TNFa by explants of adipose tissue from obese subjects. Circulating TNFa levels were below the sensitivity of their assay. 1 However, Bruun et al 2 recently
reported that obese humans with an average body mass index (BMI) of 39 kg/m 2 had a fall in plasma TNFa from 1.5 to 0.9 pmoles/l after 20 weeks of weight reduction. Dandona et al, 3 Zahorska-Markiewicz et al, 4 Laimer et al, 5 Yudkin et al, 6 and Berberoglu, 7 all observed elevated serum TNFa in obesity. However, Pincelli et al 8 The preponderance of evidence supports the hypothesis that the amount of TNFa mRNA and TNFa release by adipose tissue are enhanced in human obesity. Mohamed-Ali et al 12 could not find any TNFa in a vein draining subcutaneous adipose tissue suggesting that TNFa is not a hormone released by adipose tissue into the circulation. Our studies were designed to determine the source within adipose tissue of the elevated secretion of TNFa seen in obesity and why this enhanced secretion is not necessarily reflected in circulating TNFa.
Materials and methods
Abdominal subcutaneous and visceral adipose tissue were obtained from subjects who were undergoing open abdominal surgery (abdominoplasty) or laparoscopic gastric bypass with Roux-en-y gastroenterostomy surgery for the treatment of morbid obesity. All subjects were women. Each experimental replication involved tissue from a separate individual. The study had the approval of the local IRB and all patients involved gave their informed consent. The patients were on a clear liquid diet the day prior to surgery but had not been on any type of dietary restriction prior to surgery. Abdominal subcutaneous and visceral adipose tissue samples were kept at 371C and immediately transported to the laboratory after removal from the subject. The handling of tissue and cells was done under aseptic conditions. The tissue was cut with scissors into small pieces (10-30 mg) . All the studies utilized explants of adipose tissue that had been incubated in buffer plus albumin (3 ml/g of tissue) for approximately 30 min to remove diffusible factors and blood cells. At the conclusion of this incubation, the tissue explants were centrifuged for 30 s at 400 g in order to remove erythrocytes and pieces of tissue containing insufficient adipocytes to float. The explants were separated from the medium plus the sedimented cells and tissue fragments then resuspended in fresh buffer. The explants (500 mg/5 ml) were incubated in duplicate for 48 h in suspension culture under aseptic conditions.
In order to obtain isolated adipocytes 1 g of cut tissue, again in duplicate, was incubated in 2 ml of incubation medium containing 1.3 mg of bacterial collagenase in a rotary water bath shaker (100 r.p.m.) for 2 h. The collagenase digest was then separated from undigested tissue matrix by filtration through 200 mm mesh fabric. A volume of 5 ml of medium was then added back to the digestion tubes and used to wash the undigested matrix on the mesh fabric. This wash solution was combined with the digest containing the cells that passed through the 200 mm filter and the cells that did not float (stromovascular cells, SV cells) were separated from adipocytes and medium by centrifugation in 15 ml tubes for 1 min at 400 g. The SV cells and adipocytes were separately resuspended in 5 ml of fresh buffer and centrifuged for 10 s at 400 g. The medium was removed and the undigested tissue matrix on the mesh, the SV cells and the adipocytes were then incubated in a volume of 5 ml for the indicated periods.
The buffer for incubation of adipose tissue and adipocytes was Dulbecco's modified Eagle's medium/Ham's F12 (1 : 1, Sigma No. 2906) containing 17.5 mM glucose, 121 mM of NaCl, 4 mM of KCl, 1 mM of CaCl 2 , 25 mM of HEPES, 2.4 mM of sodium bicarbonate, 10 mg/ml of bovine serum albumin, 5 mg/ml of ethanolamine, 0.1 ng/ml of sodium selenite, 90 mg/ml of penicillin G, 150 mg/ml of streptomycin sulfate, 50 mg/ml of gentamicin and 55 mM of ascorbic acid. The pH of the buffer was adjusted to 7.4 and then filtered through a 0.2 mm filter. Aliquots of the medium were taken at 48 h and stored at 201C for measurement of release to the medium. 
Results
TNFa release by adipose tissue is elevated in obesity but prior studies on release of TNFa have used variable incubation periods ranging from 2, 1,13 20 14 to 48 h. 15, 16 The release of TNFa by explants of human adipose tissue was maximal or near-maximal at 4 h of incubation, and there was no further net increase in TNFa over the next 44 h ( Figure 1 ). By 24 and 48 h, there was actually a net decrease in TNFa accumulation ( Figure 1 ). The vast majority of the TNFa released by adipose tissue was due to the nonfat cells. We corrected for the effects of the collagenase digestion by comparing the release by adipocytes with that by the undigested adipose tissue matrix and the SV cells isolated by collagenase digestion from 1 g of adipose tissue ( Figure 1 ). The data are not corrected for any loss during collagenase digestion such as lysis of adipocytes or for loss during the washing of the three fractions to TNFa release by human fat JN Fain et al remove collageanse. The matrix is the undigested tissue residue remaining after collagenase digestion that does not pass through a 200 mm diameter mesh fabric. The SV cells are those cells released from the tissue during collagenase digestion that do not float. The release of TNFa by adipocytes was less than 5% of the amount released by the combined SV and matrix fractions from the same amount of tissue at time periods of 24 h or less and 9% at 48 h ( Figure 1) .
We compared the relative contribution of the SV cells, adipose tissue matrix and adipocytes to the release of lactate and six adipokines in the studies shown in Table 1 . Net release to the medium by the three fractions combined over 4 h of PAI-1 and TNFa was 310 and 153%, respectively, of that by tissue indicating an upregulation of their release by collagenase digestion. In contrast, IL-6 release by the three fractions was 109% of that by tissue, while recovery of lactate was 64% in the three fractions. However, the formation by the three fractions combined of HGF was 37%, while that of adiponectin was 45% and that of leptin was 30%.
The release of TNFa by the cells of the adipose tissue matrix was less than that by the SV cells which was in striking contrast to the release of IL-6 which was 10-fold greater by cells of the adipose tissue matrix than by the free SV cells ( Table 1 ). The release of lactate, HGF, PAI-1 and adiponectin by the matrix was at least five-fold greater than that by the SV cells (Table 1) . However, leptin was primarily released by adipocytes while adiponectin was released by the matrix fraction as well as by adipocytes. The release of TNFa by adipocytes as % of that by tissue explants was quite small and less than half that of IL-6 and HGF, while it was onefourth that of PAI-1 (Table 1 ). These data suggest that TNFa is primarily made by cells in the SV fraction, while IL-6, PAI-1 and HGF are primarily made by cells in the adipose tissue matrix in contrast to leptin that is primarily a product of adipocytes.
We compared the release of TNFa from subcutaneous adipose tissue explants with that by the visceral adipose tissue explants as well as that by visceral matrix, SV cells and adipocytes ( Figure 2 ). No differences were seen with respect to TNFa release by any fraction from visceral as opposed to subcutaneous adipose tissue.
The release of TNFa by adipose tissue explants correlated with the BMI of the individuals from whom the samples were obtained (Figure 3a) . There was also a significant inverse relationship between TNFa release by human adipose tissue explants over 4 h and adiponectin release over 48 h by the same tissue samples (Figure 3b) .
The decline in TNFa release between 8 and 48 h of incubation could involve a decrease in rate of synthesis either accompanied by an increase or no change in the rate of degradation. In experiments where there were low levels of TNFa at 24 h, because the tissue was obtained from individuals with an average BMI of 30 kg/m 2 , the degradation of TNFa by explants was examined between 24 and 48 h of incubation. Exogenous TNFa was added to adipose tissue explants and its disappearance was examined over the next 24 h. The data in Figure 4 indicate that the half-time for degradation of TNFa was approximately 10 h. We also examined the disappearance of TNFa in the presence of adipose tissue matrix, SV cells or adipocytes and found a similar time course (data not shown). The time course of accumulation of TNFa was markedly different from that of all other adipokines we have measured. For example, the accumulation of IL-6 after 4 h of incubation was 8% of that seen at 48 h (unpublished experiments) while that of TNFa was greater at 4 h than at 48 h (Figure 1 ) the average release of TNFa was 30 fmoles/g, and this was not significantly affected by 10 nM insulin ( þ 19728% as the mean % change7the s.e.m. of the paired differences). These data suggested that there was a correlation between BMI and TNFa accumulation by human adipocytes over 48 h as was found to be the case ( Figure 5 ). The correlation coefficient was 0.52 which was significant (P ¼ 0.001). The data also demonstrate the large variation from one individual to the next (0-60 fmoles/g) in the net accumulation of TNFa by adipocytes over 48 h.
Discussion
The present results indicate that the vast majority of the TNFa released by human adipose tissue explants comes from the nonfat cells of adipose tissue. Even after incubation of adipocytes for 48 h, the average contribution of adipocytes to total TNFa release was only 9%. This is in contrast to the finding in rodents where more TNFa mRNA has been Explants of human adipose tissue (100 mg/ml) were incubated for 18 h prior to the addition of 7 pM TNFa. The explants were then incubated for 24 h and the medium TNFa content measured at the start of the incubation, at 8 and at 24 h. The data are the mean7s.e.m. of four paired experiments using subcutaneous adipose tissue and the TNFa content in the medium at 8 and 24 h is shown as % of the initial value. The finding of a negative correlation between adiponectin release and TNFa release by human adipose tissue explants is novel but hardly unexpected since circulating levels of adiponectin are inversely related to the extent of obesity in humans.
19-21 Furthermore Kern et al 22 found a negative correlation of À0.48 (Po0.05) between the level of adiponectin mRNA and that of TNFa in human subcutaneous adipose tissue. They also reported a similar inverse relationship between the release of TNFa over a 2-h incubation by explants of human adipose tissue and the adiponectin mRNA content of freshly isolated adipose tissue. These data do not prove a causal relationship between elevated TNFa release and reduced adiponectin release by human adipose tissue as the BMI increases since both could be secondary to some more fundamental change. Leptin release by adipose tissue like that of TNFa is enhanced in obesity, but it is unlikely that there is a causal relationship since in human adipocytes the direct addition of TNFa actually inhibits leptin release over a 48-h incubation. 23, 24 However, the current paradigm is that TNFa is a direct inhibitor of the synthesis by adipocytes of leptin as well as adiponectin. 25 We could find no difference in the release of TNFa by subcutaneous as contrasted to that by visceral adipose tissue, the adipose tissue matrix, the SV cells or adipocytes. These data agree with the finding of Dusserre et al 26 Human adipose tissue cultured under our conditions did not demonstrate further net secretion of TNFa after about 8 h in primary culture. This was probably due to a balance between formation and degradation of TNF since we found that the half-life for immunoreactive TNFa added to adipose tissue previously incubated for 18 h was about 10 h. We attempted to enhance net accumulation of TNFa by the use of a combination of protease inhibitors (aprotinin, bestatin, E-64, leupeptin plus pepstatin). However, we found that over a 4-h incubation they reduced TNFa accumulation by 12% and at 24 or 48 h had no effect (unpublished experiments). This might be due to the fact that TNFa is synthesized as a 26-kDa protein that must be processed to release the 17-kDa soluble form 32 ). However, it is something that does not require the presence of the nonfat cells in the tissue and may reflect prior exposure in vivo to some regulatory stimulus.
We confirmed upregulation of TNFa release by lipopolysaccharide in human adipose tissue that is well-established in macrophages 18 and was previously reported by Sewter et al. 14 The marked inhibition of TNFa release by NFA, an inhibitor of cyclooxygenase-2, was unexpected and suggests a prominent role of reactive oxygen species in the TNFa release. Similar results have been seen during primary culture of glial cells where the release of TNFa due to a neurotoxicant was blocked by indomethacin, a nonspecific cyclooxygenase inhibitor. 33 Since prostanoids such as PGE 2 actually block TNFa release by glial cells, 33 Kupffer cells 34 and human blood TNFa release by human fat JN Fain et al mononuclear cells 35 the paradoxical inhibition of TNFa release by cyclooxygenase inhibitors was attributed to their ability to block the formation of reactive oxygen species which are generated by cyclooxygenases. 33 We found that the release of IL-6 by explants of human adipose tissue was 100-fold greater than that of TNFa over a 4-h incubation. Clearly, far more IL-6 is released by human adipose tissue than is the case for TNFa. In agreement with this, Mohamed-Ali et al 12 found a significant arteriovenous difference in IL-6 but not in TNFa across abdominal subcutaneous adipose tissue. We conclude that the release of TNFa by human adipose tissue is primarily by the nonfat cells present in the tissue. The release of TNFa by adipocytes and adipose tissue correlated with the BMI of the fat donors and release by tissue of TNFa was inversely related to that of adiponectin.
